Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00006051
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
UNICANCER
Testing effectiveness (Phase 2)UnknownNCT00625937
What this trial is testing

Docetaxel and S-1 Followed By Radiation Therapy and Low-Dose Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Yonsei University 46
Large-scale testing (Phase 3)Study completedNCT00002670
What this trial is testing

Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer That Has Been Removed During Surgery

Who this might be right for
Head and Neck Cancer
Radiation Therapy Oncology Group 459
Early research (Phase 1)Study completedNCT00089362
What this trial is testing

Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors

Who this might be right for
Male Breast CancerRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+73 more
National Cancer Institute (NCI) 30
Large-scale testing (Phase 3)Looking for participantsNCT04333537
What this trial is testing

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

Who this might be right for
Buccal Mucosa Squamous Cell CarcinomaFloor of Mouth Squamous Cell CarcinomaGingival Squamous Cell Carcinoma+9 more
NRG Oncology 686
Large-scale testing (Phase 3)Study completedNCT00003809
What this trial is testing

Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00003565
What this trial is testing

Docetaxel in Treating Patients With Solid Tumors

Who this might be right for
Bladder CancerBreast CancerHead and Neck Cancer+2 more
Alliance for Clinical Trials in Oncology 109
Early research (Phase 1)Study completedNCT00003200
What this trial is testing

Chemotherapy Plus Radiation Therapy in Treating Patients With Squamous Cell Cancer of the Head and Neck

Who this might be right for
Head and Neck Cancer
Dana-Farber Cancer Institute 22
Early research (Phase 1)Study completedNCT01334177
What this trial is testing

TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+38 more
University of Washington 13
Large-scale testing (Phase 3)Looking for participantsNCT06589804
What this trial is testing

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

Who this might be right for
Metastatic Head and Neck Squamous Cell CarcinomaMetastatic Hypopharyngeal Squamous Cell CarcinomaMetastatic Laryngeal Squamous Cell Carcinoma+18 more
National Cancer Institute (NCI) 158
Not applicableLooking for participantsNCT01473784
What this trial is testing

Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck

Who this might be right for
Recurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Mucoepidermoid Carcinoma of the Oral CavityRecurrent Squamous Cell Carcinoma of the Hypopharynx+48 more
Ohio State University Comprehensive Cancer Center 600
Testing effectiveness (Phase 2)Study completedNCT00064298
What this trial is testing

Fruit and Vegetable Extracts in Treating Patients With Stage I-IV, Stage IVA/IVB Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Wake Forest University Health Sciences 134
Testing effectiveness (Phase 2)Study completedNCT00055770
What this trial is testing

Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck Cancer

Who this might be right for
Recurrent Salivary Gland CancerRecurrent Squamous Cell Carcinoma of the HypopharynxRecurrent Squamous Cell Carcinoma of the Larynx+19 more
National Cancer Institute (NCI) 45
Not applicableStudy completedNCT00843635
What this trial is testing

Tadalafil in Treating Patients Undergoing Surgery for Cancer of the Oral Cavity or Oropharynx

Who this might be right for
Head and Neck Cancer
Donald T. Weed 35
Early research (Phase 1)Study completedNCT00006036
What this trial is testing

Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Head and Neck CancerLung CancerOvarian Cancer+1 more
NCIC Clinical Trials Group 14
Not applicableStudy completedNCT00483821
What this trial is testing

A Retrospective Analysis of Neck Dissection Following Complete Response to Chemoradiation in HNSCC

Who this might be right for
Head and Neck Cancer
Vanderbilt-Ingram Cancer Center 165
Not applicableUnknownNCT00415298
What this trial is testing

AP5346 or Oxaliplatin in Treating Patients With Metastatic and/or Unresectable Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
University of California, San Diego 12
Testing effectiveness (Phase 2)Study completedNCT00513435
What this trial is testing

Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Squamous Cell Carcinoma of the Hypopharynx+36 more
National Cancer Institute (NCI) 9
Early research (Phase 1)Active Not RecruitingNCT04576091
What this trial is testing

Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer

Who this might be right for
Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Recurrent Head and Neck Cutaneous Squamous Cell Carcinoma+29 more
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Ended earlyNCT00113399
What this trial is testing

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery

Who this might be right for
Head and Neck Cancer
Radiation Therapy Oncology Group 15
Next Page
7